FDA Warns Philips Over Fatal Defibrillator Defects
The letter, dated March 28, was sent to Philips Medical Systems Inc., and was posted on the FDA’s website this week. The FDA had issued a previous warning letter to Philips in 2009.
According to the letter, FDA inspectors determined that the HeartStart, FRx, FR2+ and HS1...
To view the full article, register now.